Results

Total Results: 489 records

Showing results for "psa".
Users also searched for: aspirin

181. Building a Safety Program in a Vast Health Care Network | PSNet
     psnet.ahrq.gov/perspective/building-safety-program-vast-health-care-network
     March 01, 2019 - This practice called professional services agreements, or PSA, where an individual or a group of physicians … The range of system expansion can be from a single PSA physician that's independent of any bigger whole … This PSA [professional services agreement] thing is just enormous. … We (Ariadne) are working through the PSA process for surgery. … We have developed a list of questions that a PSA surgeon would want to know going to a new hospital alone

182. Understanding and Reducing Overuse of Potentially Harmful Screening Tests (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/sheridan_screening_overuse.pdf
     January 01, 2014 - focused on a number of services that are not recommended, such as using the prostate-specific antigen (PSA

183. Final Progress Report: Developing an HIV-Specific Prevention Index Using the Electronic Medical Record (pdf file)
     www.ahrq.gov/sites/default/files/2025-02/meenan-report.pdf
     January 01, 2025 - virus (HIV): CD4, VL, lipids, BP, flu, DTAP, Pneumovax, Hep A, Hep B, gonorrhea, chlamydia, CRC, PSA … colon pain Barium enema, 2 years 24 Ulcerative colitis Crohn's disease Prostate cancer screening (PSA … ) Male, age 50+ Annual 12 Prostate cancer Abnormal PSA test PSA within 90 days of previous Tests recurring … cr e en in g KP A KP B KP C KP D Figure 16 (Colorectal cancer (CRC) screening) and Figure 17 (PSA … Prostate‐specific antigen (PSA) screening Prevention Index 0 10 20 30 40 50 60 70 80 90 100

184. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
     July 29, 2010 - commercially available PCA3 expression assays for prostate cancer screening tests vs. screening by PSA

185. Diagnostic Errors Case Studies | PSNet
     psnet.ahrq.gov/curated-library/diagnostic-errors-case-studies
     May 05, 2025 - A physician assistant saw him at that first visit and ordered a PSA test (despite the patient's expressed … views against PSA testing) and cystoscopy (without explaining why it was needed), and urged the patient

186. eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/r21hs021797-mohan-annual-summary-2012.pdf
     January 01, 2012 - The use of prostate-specific antibody (PSA) as a screening test has led to earlier diagnosis of prostate

187. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/23.html
     June 08, 2018 - Below are some questions you may want to ask your doctor: What are my PSA level, Gleason Score,

188. Understanding Physicians' and Patients' Views of Harms and Clinical Preventive Services (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/vu_physician_patient_harms.pdf
     September 18, 2014 - Clinicians could name harms of screening for prostate cancer using the Prostate Specific Antigen test (PSA

189. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=333
     January 01, 2024 - This study investigated whether psoriasis (Pso) and psoriatic arthritis (PsA) are associated with osteoporosis … Using records of 183,725 persons with Pso and 28,765 with PsA from the 2006-2012 National Emergency Department … including 20 percent of the emergency care visits throughout the United States, it found that Pso and PsA

190. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=367
     January 01, 2024 - The researchers evaluated the potential cost-effectiveness of plausible prostate-specific antigen (PSA … They found that, with contemporary treatment, only strategies with biopsy referral for PSA levels higher … They concluded that, for PSA screening to be cost-effective, it needs to be used conservatively and ideally

191. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-2007/research
     December 01, 2019 - biologic DMARDs in the treatment of patients with either rheumatoid arthritis (RA) or psoriatic arthritis (PsA

192. Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/prostate-cancer
     September 17, 2020 - You may also get a blood test for prostate-specific antigen (PSA).

193. Mapping a Large Patient Safety Database to the 2005 Patient Safety Event Taxonomy (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Clarke_8.pdf
     January 25, 2008 - Available at: www.psa.state.pa.us/psa/lib/psa/act_13/act_13.pdf. Accessed January 25, 2008. 4. … Sudbury MA: Jones & Bartlett; 2004. p. 169-186. 13 http://www.psa.state.pa.us/psa/lib/psa/act_13

194. Understanding and Reducing Overuse of Potentially Harmful Screening Tests (pdf file)
     healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/sheridan_screening_overuse.pdf
     January 01, 2014 - focused on a number of services that are not recommended, such as using the prostate-specific antigen (PSA

195. Understanding and Reducing Overuse of Potentially Harmful Screening Tests (pdf file)
     monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/sheridan_screening_overuse.pdf
     January 01, 2014 - focused on a number of services that are not recommended, such as using the prostate-specific antigen (PSA

196. Understanding and Reducing Overuse of Potentially Harmful Screening Tests (pdf file)
     cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/sheridan_screening_overuse.pdf
     January 01, 2014 - focused on a number of services that are not recommended, such as using the prostate-specific antigen (PSA

197. Understanding and Reducing Overuse of Potentially Harmful Screening Tests (pdf file)
     talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/sheridan_screening_overuse.pdf
     January 01, 2014 - focused on a number of services that are not recommended, such as using the prostate-specific antigen (PSA

198. Understanding and Reducing Overuse of Potentially Harmful Screening Tests (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/sheridan_screening_overuse.pdf
     January 01, 2014 - focused on a number of services that are not recommended, such as using the prostate-specific antigen (PSA

199. Task Force Resources | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-resources
     May 04, 2025 - USPSTF’s 2018 prostate cancer recommendation and explains the benefits and harms of screening using the PSA

200. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
     September 12, 2019 - or ablated. 3 , 4 Instead, tumors are monitored through surveillance of prostate specific antigen (PSA … patient characteristics (e.g., age, ethnicity, comorbidities, preferences), tumor characteristics (e.g., PSA … Baseline PSA Gleason score Tumor index scores (e.g., Cancer of the Prostate Risk Assessment Score … hormone-releasing hormone MRI= magnetic resonance imaging NCCN= National Comprehensive Cancer Network PSA